Health group CEPI to help fund Indian drugmakers COVID-19 vaccine

▴ Health group CEPI to help fund Indian drugmakers COVID-19 vaccine
CEPI finances vaccine efforts

The Coalition for Epidemic Preparedness Innovations (CEPI) will help fund the production of a COVID-19 vaccine by Indian drugmaker Biological E. Ltd, the global epidemic response group said on Tuesday.

CEPI will contribute an initial amount of up to $5 million and will consider providing more funding to help produce 100 million doses of the potential vaccine next year, the group and Biological E. said in a joint statement

The Hyderabad-based company’s COVID-19 vaccine candidate is currently in early- to mid-stage trials, with plans to start late-stage trials in April.

Indian health authorities expect to begin a vaccination drive for some 300 million people early next month in the country that accounts for the world’s second-highest coronavirus infections at about 10.22 million, but has seen a decline in daily cases since a peak in September.

“(Biological E.’s) vaccine candidate has the potential to be produced at scale, and characteristics which could make it suitable for broad distribution in developing countries,” said Richard Hatchett, chief executive officer of CEPI.

Norway-based CEPI, along with the GAVI vaccine alliance and the World Health Organization, leads the COVAX alliance that aims to secure fair access to COVID-19 vaccines for poor countries. CEPI is backed by 14 governments, the Bill and Melinda Gates Foundation and Britain’s Wellcome Trust.

Story Source 

Tags : #CEPI #CovidVaccine #Covid19Vaccine #GAVI #Covax

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024